CFDE Data Portal | Search SLC6A12-AS1

	Label	Description
	SLC6A12-AS1 Gene (Entity type)	ENSG00000256577 - SLC6A12 antisense RNA 1
	GSE172016 paclitaxel 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE158552 BRD4 inhibition 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 6 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE236228 penfluridol 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 3 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE213845 EZH2 inhibition 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE109228 OPA1 inhibition neuron 1-Methyl-4-phenyl-1 2 3 6-tetrahydropyridine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE109228 dopamine neuron 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE97352 1 V 2 DASATINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

SLC6A12-AS1

ENSG00000256577 - SLC6A12 antisense RNA 1

GSE172016 paclitaxel 2 v 1 human up

A Gene Set from LINCS

GSE158552 BRD4 inhibition 2 v 0 human dn

A Gene Set from LINCS

GSE77108 saha 6 v 2 human dn

A Gene Set from LINCS

GSE236228 penfluridol 0 v 1 human up

A Gene Set from LINCS

GSE143782 calcitriol 3 v 11 human dn

A Gene Set from LINCS

GSE213845 EZH2 inhibition 2 v 0 human up

A Gene Set from LINCS

GSE109228 OPA1 inhibition neuron 1-Methyl-4-phenyl-1 2 3 6-tetrahydropyridine 0 v 1 human up

A Gene Set from LINCS

GSE109228 dopamine neuron 0 v 1 human up

A Gene Set from LINCS

GSE97352 1 V 2 DASATINIB HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.